Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vendruscolo

Showing results (681-690 of 816) with videos related to

Pageof 82
Sort By:
Mabs|December 8, 2018
In vitro and in silico assessment of the developability of a designed monoclonal antibody libraryAdriana-Michelle Wolf Pérez, Pietro Sormanni, Jonathan Sonne Andersen, et al.
Journal of Toxicology and Environmental Health. Part A|July 14, 2025
<i>Myrciaria dubia (Kunth) McVaugh</i> hydroalcoholic extract with bioactive compounds, antitumor and photoprotective activity against UVB radiationMariana Tonello Biffi, Ingrithy Vendruscolo, Israel Keller Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2025
Global kinetic model of lipid-induced <i>α</i>-synuclein aggregation and its inhibition by small moleculesAlisdair Stevenson, Roxine Staats, Alexander J Dear, et al.
Nature Chemistry|April 15, 2020
Dynamics of oligomer populations formed during the aggregation of Alzheimer's Aβ42 peptideThomas C T Michaels, Andela Šarić, Samo Curk, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
The NK1 receptor antagonist L822429 reduces heroin reinforcementEstelle Barbier, Leandro F Vendruscolo, Joel E Schlosburg, et al.
Nature Chemistry|April 19, 2020
Author Correction: Dynamics of oligomer populations formed during the aggregation of Alzheimer's Aβ42 peptideThomas C T Michaels, Andela Šarić, Samo Curk, et al.
Science (New York, N.Y.)|December 16, 2017
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomersGiuliana Fusco, Serene W Chen, Philip T F Williamson, et al.
Acta Neuropathologica Communications|December 5, 2019
A metastable subproteome underlies inclusion formation in muscle proteinopathiesPrajwal Ciryam, Matthew Antalek, Fernando Cid, et al.
Science Advances|April 20, 2019
Secondary nucleation and elongation occur at different sites on Alzheimer's amyloid-β aggregatesTom Scheidt, Urszula Łapińska, Janet R Kumita, et al.
Nature Communications|November 17, 2023
Sequence-based prediction of the intrinsic solubility of peptides containing non-natural amino acidsMarc Oeller, Ryan J D Kang, Hannah L Bolt, et al.
Pageof 82

Showing results (681-690 of 816) with videos related to

Sort By:
Pageof 82
Mabs|December 8, 2018
In vitro and in silico assessment of the developability of a designed monoclonal antibody libraryAdriana-Michelle Wolf Pérez, Pietro Sormanni, Jonathan Sonne Andersen, et al.
Journal of Toxicology and Environmental Health. Part A|July 14, 2025
<i>Myrciaria dubia (Kunth) McVaugh</i> hydroalcoholic extract with bioactive compounds, antitumor and photoprotective activity against UVB radiationMariana Tonello Biffi, Ingrithy Vendruscolo, Israel Keller Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2025
Global kinetic model of lipid-induced <i>α</i>-synuclein aggregation and its inhibition by small moleculesAlisdair Stevenson, Roxine Staats, Alexander J Dear, et al.
Nature Chemistry|April 15, 2020
Dynamics of oligomer populations formed during the aggregation of Alzheimer's Aβ42 peptideThomas C T Michaels, Andela Šarić, Samo Curk, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
The NK1 receptor antagonist L822429 reduces heroin reinforcementEstelle Barbier, Leandro F Vendruscolo, Joel E Schlosburg, et al.
Nature Chemistry|April 19, 2020
Author Correction: Dynamics of oligomer populations formed during the aggregation of Alzheimer's Aβ42 peptideThomas C T Michaels, Andela Šarić, Samo Curk, et al.
Science (New York, N.Y.)|December 16, 2017
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomersGiuliana Fusco, Serene W Chen, Philip T F Williamson, et al.
Acta Neuropathologica Communications|December 5, 2019
A metastable subproteome underlies inclusion formation in muscle proteinopathiesPrajwal Ciryam, Matthew Antalek, Fernando Cid, et al.
Science Advances|April 20, 2019
Secondary nucleation and elongation occur at different sites on Alzheimer's amyloid-β aggregatesTom Scheidt, Urszula Łapińska, Janet R Kumita, et al.
Nature Communications|November 17, 2023
Sequence-based prediction of the intrinsic solubility of peptides containing non-natural amino acidsMarc Oeller, Ryan J D Kang, Hannah L Bolt, et al.
Pageof 82